Cable Hill Partners’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,112
| Closed | -$25K | – | 802 |
|
|
2019
Q1 | $25K | Buy |
1,112
+500
| +82% | +$11.2K | 0.01% | 344 |
|
|
2018
Q4 | $15K | Buy |
612
+500
| +446% | +$12.3K | 0.01% | 389 |
|
|
2018
Q3 | $3K | Sell |
112
-20
| -15% | -$536 | ﹤0.01% | 685 |
|
|
2018
Q2 | $4K | Hold |
132
| – | – | ﹤0.01% | 749 |
|
|
2018
Q1 | $4K | Sell |
132
-216
| -62% | -$6.55K | ﹤0.01% | 740 |
|
|
2017
Q4 | $13K | Hold |
348
| – | – | 0.01% | 515 |
|
|
2017
Q3 | $9K | Sell |
348
-8
| -2% | -$207 | ﹤0.01% | 621 |
|
|
2017
Q2 | $7K | Sell |
356
-1
| -0.3% | -$20 | ﹤0.01% | 496 |
|
|
2017
Q1 | $8K | Buy |
357
+5
| +1% | +$112 | ﹤0.01% | 461 |
|
|
2016
Q4 | $7K | Hold |
352
| – | – | ﹤0.01% | 493 |
|
|
2016
Q3 | $6K | Sell |
352
-38
| -10% | -$648 | ﹤0.01% | 541 |
|
|
2016
Q2 | $5K | Hold |
390
| – | – | ﹤0.01% | 519 |
|
|
2016
Q1 | $6K | Buy |
+390
| New | +$6K | ﹤0.01% | 460 |
|